🇮🇳IN
Sign In
LI

LINCOLN

NSE

Lincoln Pharmaceuticals Limited

₹504.35

-10.25(-1.99%)

Group Companies

Foreign Flows

sector level — not this stock
Healthcare sector+₹3 Crnet foreign buying
2026-09-16 to 2026-09-end

This is the flow into the whole Healthcare sector, not into LINCOLN. We report it at the level it is measured — attributing a sector figure to one company would be inventing a number nobody published.

Supply Chain

suppliers and customers in the graph

Relationship Network

directors, institutions, group entities

Macro Sensitivity

rates, currency, commodities

Revenue by Segment

Business Group

Geographic Exposure

revenue, imports, currency

Scenario analysis

stated assumptions, shown workings

LINCOLN exposure summary

Lincoln Pharmaceuticals Limited reports a single business segment, The Company is engaged in the business of manufacturing and selling of Pharmaceuticals formulations as well as undertakes contract manufacturing from reputed pharmaceuticals companies. Lincoln Pharmaceuticals Limited is a constituent of 2 indices.

Index memberships2

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer